Next Article in Journal
The Role of Non-Coding RNAs in the Regulation of the Proto-Oncogene MYC in Different Types of Cancer
Next Article in Special Issue
Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment
Previous Article in Journal
Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson’s Disease
Previous Article in Special Issue
Experimental Models for the Study of Hereditary Cornification Defects
 
 
Review

Differential Diagnosis and Treatment of Itching in Children and Adolescents

Department of Dermatology, Kangnam Sacred Heart Hospital, Hallym University, Seoul KS013, Korea
*
Author to whom correspondence should be addressed.
Authors equally contributed.
Academic Editor: Franco Cervellati
Biomedicines 2021, 9(8), 919; https://doi.org/10.3390/biomedicines9080919
Received: 29 June 2021 / Revised: 22 July 2021 / Accepted: 22 July 2021 / Published: 30 July 2021
(This article belongs to the Special Issue Pediatric Dermatology and Inherited Skin Diseases)
Itching is prevalent in children with skin disorders and associated with effects on their mood, quality of life, and social functioning. Surprisingly, there are no data on childhood prevalence of pruritus in the general population. The aim of this article is to explore the epidemiology, clinical manifestation, and treatment for itch (pruritus) in the pediatric population (from infancy to adolescence), and to be helpful to primary care physicians who assess and diagnose pediatric patients with itching. In this study, we searched for specific keywords using PubMed and MEDLINE (Ovid) and, then, refined the retrieved searches for each cause and treatment. As a result of reviewing the literature, atopic dermatitis was shown to be the most common cause of itching, especially during infancy and through preschool. Not only skin disorders but also systemic diseases, drugs, and postburn states can predispose an individual to itching in childhood. There are traditional and newly developed treatment modalities for itching in pediatric patients. However, because the pharmacokinetics and pharmacodynamics of childhood are different from those of adults, the medications for itching have to be applied carefully for these age groups. There are many areas to be elucidated regarding the prevalence and objective assessment of pruritus in pediatric patients. Moreover, the safety profiles of medications in the pediatric population need to be better understood. Further studies to investigate itching in childhood are warranted. View Full-Text
Keywords: children; adolescents; itching; pruritus; differential diagnosis; treatment of itching children; adolescents; itching; pruritus; differential diagnosis; treatment of itching
Show Figures

Figure 1

MDPI and ACS Style

Kang, S.-Y.; Um, J.-Y.; Chung, B.-Y.; Kim, J.-C.; Park, C.-W.; Kim, H.-O. Differential Diagnosis and Treatment of Itching in Children and Adolescents. Biomedicines 2021, 9, 919. https://doi.org/10.3390/biomedicines9080919

AMA Style

Kang S-Y, Um J-Y, Chung B-Y, Kim J-C, Park C-W, Kim H-O. Differential Diagnosis and Treatment of Itching in Children and Adolescents. Biomedicines. 2021; 9(8):919. https://doi.org/10.3390/biomedicines9080919

Chicago/Turabian Style

Kang, Seok-Young, Ji-Young Um, Bo-Young Chung, Jin-Cheol Kim, Chun-Wook Park, and Hye-One Kim. 2021. "Differential Diagnosis and Treatment of Itching in Children and Adolescents" Biomedicines 9, no. 8: 919. https://doi.org/10.3390/biomedicines9080919

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop